Company intelligence / Profile preview
Dongwha Pharmaceutical Co., Ltd.
Seoul, South Koreadong-wha.co.kr ↗
- Ownership
- Private
- Employees
- ~816
- Development stage
- Preclinical
01
Overview
Dongwha Pharmaceutical has multiple approved drugs including DW-166HC for Hemophilia A, Dapagliflozin/Sitagliptin for Type 2 Diabetes, Zabofloxacin D-aspartate for Respiratory Tract Infections, Loxoprofen Sodium Hydrate for Pain, and Choline Alfoscerate for Cognition Disorders[9]. The company is also developing new treatments including a sarcopenia treatment in collaboration with Animuscure[6].
- Therapeutic areas
- Metabolic DisordersPulmonologyEndocrinologyOncologyImmunologyHematologyNeurologyInfectious Diseases
- Modalities
- Small molecule drugsBiological productsTherapeutic radiopharmaceuticalsFixed-dose combinationsProbiotics
- Industry
- Biotech
02
Drug pipeline
17 assets16 more assets in the full pipeline.
03
Partnerships
Animuscure (for sarcopenia treatment development)[6]Previously had partnership with GSK Consumer Healthcare Korea (ended)[8]
Beyond the preview
Go deeper on Dongwha Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dongwha Pharmaceutical Co., Ltd..